Cellipont Bioservices
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cellipont Bioservices - overview
Established
2002
Location
-, CA, US
Primary Industry
Biotechnology
About
Founded in 2002 and based in California, US, Cellipont Bioservices, formerly known as Performance Cell Manufacturing, operates as a cell therapy contract development and manufacturing organization (CDMO) that is primarily engaged in cell therapy development and small-to-large batch production. In January 2022, Great Point Partners acquired Performance Cell Manufacturing, Inc. As part of the transaction, Performance Cell Manufacturing, Inc. rebranded as Cellipont Bioservices.
As of 2022, Deborah Wild is the president and CEO of the company. In October 2024, HealthQuest Capital and Great Point Partners invested in Cellipont Bioservices. Financial terms were not disclosed. The company's capabilities include cGMP manufacturing, analytical method development, process development, GMP quality control lab, method and process validation, documentation and batch record development, cGMP stability, regulatory support for filings and inspections, sterile fill/finish, and program management.
The firm also offers multiple product areas in CAR-T, iNK, dendritic cell, and other novel cell therapy approaches such as autologous and allogeneic cell therapies.
Current Investors
Great Point Partners, HealthQuest Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.cellipont.com
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Cellipont Bioservices - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Cellipont Bioservices | - | ||||||||
| Private Debt | Completed | Cellipont Bioservices | - | ||||||||
| Buyout | Completed | Cellipont Bioservices | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.